Literature DB >> 1531498

Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.

M Pompeiano1, J M Palacios, G Mengod.   

Abstract

In order to localize the cells expressing 5-HT1A receptors in the rat brain, we used in situ hybridization histochemistry to visualize the distribution of the mRNA coding for 5-HT1A receptors. Oligonucleotides derived from different parts of the coding region of the rat 5-HT1A receptor gene were used as hybridization probes. 5-HT1A binding sites were visualized on consecutive sections by receptor autoradiography using 3H-8-hydroxy-2-(di-n-propylamino)tetralin as ligand. The highest levels of hybridization were observed in the dorsal raphe nucleus, septum, hippocampus, entorhinal cortex, and interpeduncular nucleus. Positive hybridization signals were also present in other areas, such as the olfactory bulb; cerebral cortex; some thalamic and hypothalamic nuclei; several nuclei of the brainstem, including all the remaining raphe nuclei, nucleus of the solitary tract, and nucleus of the spinal tract of the trigeminus; and the dorsal horn of the spinal cord. The distribution and abundance of 5-HT1A receptor mRNA in different rat brain areas generally correlate with those of the binding sites, suggesting that 5-HT1A receptors are predominantly somatodendritic receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531498      PMCID: PMC6575627     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  129 in total

1.  Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting.

Authors:  N Jolimay; L Franck; X Langlois; M Hamon; M Darmon
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

3.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

4.  Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.

Authors:  Corinne Y Ostock; Kristin B Dupre; Karen L Eskow Jaunarajs; Hannah Walters; Jessica George; David Krolewski; Paul D Walker; Christopher Bishop
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

5.  In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.

Authors:  Laia Lladó-Pelfort; Marie-Bernadette Assié; Adrian Newman-Tancredi; Francesc Artigas; Pau Celada
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

Review 6.  Serotonin and prefrontal cortex function: neurons, networks, and circuits.

Authors:  M Victoria Puig; Allan T Gulledge
Journal:  Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.590

7.  Inhibition by 5-HT of the synaptic responses evoked by callosal fibers on cortical neurons in the mouse.

Authors:  José A Troca-Marín; Emilio Geijo-Barrientos
Journal:  Pflugers Arch       Date:  2010-09-14       Impact factor: 3.657

8.  Local GABAergic modulation of the activity of serotoninergic neurons in the nucleus raphe magnus.

Authors:  A N Inyushkin; N A Merkulova; A O Orlova; E M Inyushkina
Journal:  Neurosci Behav Physiol       Date:  2010-08-03

9.  Activation of serotonin 3 receptors changes in vivo auditory responses in the mouse inferior colliculus.

Authors:  Alexander Bohorquez; Laura M Hurley
Journal:  Hear Res       Date:  2009-02-21       Impact factor: 3.208

10.  Serotonergic modulation of Neural activities in the entorhinal cortex.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.